Medifast
MED
#9618
Rank
A$0.15 B
Marketcap
A$13.99
Share price
-0.81%
Change (1 day)
-34.21%
Change (1 year)

Medifast (MED) - Total debt

Total debt on the balance sheet as of March 2026 : A$22.91 Million

According to Medifast's latest financial reports the company's total debt is A$22.91 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Medifast - Total debt on balance sheet (from 2000 to 2026)

Total debt by year

Year Total debt Change
2025-12-31A$15.96 M-38.41%
2024-12-31A$25.92 M-19.76%
2023-12-31A$32.3 M-15.6%
2022-12-31A$38.28 M-14.72%
2021-12-31A$44.88 M209.25%
2020-12-31A$14.51 M-25.28%
2019-12-31A$19.42 M
2018-12-31N/A
2016-12-31N/A-100%
2015-12-31A$0.3 M-89.97%
2014-12-31A$2.99 M284.29%
2013-12-31A$0.78 M-81.3%
2012-12-31A$4.17 M-24.62%
2011-12-31A$5.53 M-3.02%
2010-12-31A$5.7 M-17.81%
2009-12-31A$6.94 M-36.63%
2008-12-31A$10.96 M48.98%
2007-12-31A$7.35 M9.17%
2006-12-31A$6.73 M-4.63%
2005-12-31A$7.06 M7.59%
2004-12-31A$6.56 M-9.3%
2003-12-31A$7.24 M31.79%
2002-12-31A$5.49 M744.72%
2001-12-31A$0.65 M-61.39%
2000-12-31A$1.68 M-23.49%
1999-12-31A$2.2 M-71.96%
1998-12-31A$7.85 M102.17%
1997-12-31A$3.88 M5.91%
1996-12-31A$3.66 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
OPKO Health
OPK
A$0.56 B 2,365.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Abeona Therapeutics
ABEO
A$32.98 M 43.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Bellerophon Therapeutics
BLPH
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA